Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2012
06/26/2012US8207233 Methods for treating diabetic foot ulcers
06/26/2012US8207227 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
06/26/2012US8207145 Using pharmaceutical preparation of mucopolysaccharides having an anticoagulant activity of <100 BP units/mg for prophylactic priming or curative treatment of the cervix and the myometrium; sulfates of heparin chondroitin and dermatan and their depolymerized products
06/26/2012US8207140 Oligomeric compounds for the modulation of HIF-1α expression
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8207135 Compositions for and methods of enhancing the immune response to antigens
06/26/2012US8207133 Peptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SGLT1
06/26/2012US8207132 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
06/26/2012US8207131 Peptide
06/26/2012US8207130 Combination cancer immunotherapy with co-stimulatory molecules
06/26/2012US8207129 Treatment with cyclosporin A
06/26/2012US8207128 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
06/26/2012US8207127 Compounds for enzyme inhibition
06/26/2012US8207126 Compounds for enzyme inhibition
06/26/2012US8207125 Compounds for enzyme inhibition
06/26/2012US8207124 Compounds for enzyme inhibition
06/26/2012US8207123 Tumour-specific animal proteins
06/26/2012US8207121 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
06/26/2012US8207120 NELL-1 enhanced bone mineralization
06/26/2012US8207119 Ophthalmological composition
06/26/2012US8207118 Skin wound healing compositions and methods of use thereof
06/26/2012US8207117 Methods of reducing hemorrhage due to surgical procedure
06/26/2012US8207116 Remedies for ischemia
06/26/2012US8207115 Treatment of cartilage disorders with FGF-18
06/26/2012US8207114 Targeted therapeutic proteins
06/26/2012US8207113 Methods for characterizing glycoproteins and generating antibodies for same
06/26/2012US8207112 Liquid formulation of G-CSF conjugate
06/26/2012US8207111 Method for treating muscular dystrophy
06/26/2012US8207110 ITL3 polypeptides and uses thereof
06/26/2012US8206989 Method of generating a dosing schedule using gamma secretase notch biomarkers
06/26/2012US8206967 Method for production of recombinant human thrombin
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206899 Prostate cancer-related compositions, methods and kits based on DNA microarray proteomics platforms
06/26/2012US8206774 Diazonium salt modification of silk polymer
06/26/2012US8206750 Charged lipoprotein complexes and their uses
06/26/2012US8206745 Solvent/polymer solutions as suspension vehicles
06/26/2012US8206743 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
06/26/2012US8206739 Fish protein hydrolyzate
06/26/2012US8206724 Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
06/26/2012US8206723 having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
06/26/2012US8206722 Somatostatin receptor antagonists and glucose control or hypoglycemia
06/26/2012US8206720 Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206718 Expression and export of angiogenesis inhibitors as immunofusins
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012US8206707 Combination therapy for the treatment of ocular neovascular disorders
06/26/2012US8206706 Method for enhancing or inhibiting insulin-like growth factor-I
06/26/2012US8206704 Use of GCC ligands
06/26/2012US8206703 High activity mutants of butyrylcholinesterase for cocaine hydrolysis
06/26/2012US8206698 Method of treating a cutaneous wound using a coiled coil chimeric molecule
06/26/2012US8206693 PMMA binding peptides
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/26/2012CA2445875C Pentapeptide compounds and uses related thereto
06/26/2012CA2432965C The use of food and drink as a delivery system for phytase in humans
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/26/2012CA2406853C Methods and compositions for eliciting an immune response
06/26/2012CA2406225C Recombinant intracellular pathogen vaccines and methods for use
06/26/2012CA2343980C Mammaglobin, a secreted mammary-specific breast cancer protein
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/26/2012CA2323785C Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
06/26/2012CA2263895C Therapeutic and diagnostic applications of perlecan domain i splice variants
06/26/2012CA2220021C Biologically active peptides and compositions, their use
06/21/2012WO2012083078A2 Croos-linked peptides and proteins, methods of making same, and uses thereof
06/21/2012WO2012082921A1 Cellular activation insulin therapy
06/21/2012WO2012082573A1 Predictive methods and methods of treating arthritis using il-17 antagonists
06/21/2012WO2012082056A1 Novel biomarker and uses thereof in diagnosis, treatment of autism
06/21/2012WO2012081711A1 Cell migration modulator
06/21/2012WO2012081531A1 Disease inhibiting agent
06/21/2012WO2012081273A1 Disease inhibiting agent
06/21/2012WO2012081227A1 Therapeutic agent for disc herniation
06/21/2012WO2012081040A1 Biological activity of placental protein 13
06/21/2012WO2012080987A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012WO2012080842A1 Recombinant laminin-521
06/21/2012WO2012080630A1 Novel therapeutic strategies for improving an anticancer treatment
06/21/2012WO2012080500A1 Serum amyloid p protein
06/21/2012WO2012080471A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/21/2012WO2012080362A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012WO2012080320A1 Fast-acting insulin in combination with long-acting insulin
06/21/2012WO2012080151A1 Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
06/21/2012WO2012079979A1 Aqueous factor viii solution
06/21/2012WO2012079435A1 Scorpion active peptides and preparation methods and applications thereof
06/21/2012WO2012079172A1 Cyclosporine analogue molecules modified at amino acid 1 and 3
06/21/2012WO2012079164A1 Activators of cylindrical proteases
06/21/2012WO2012061113A3 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
06/21/2012WO2012058220A3 Anti-sod1 antibodies and uses thereof
06/21/2012WO2012055967A3 Treating diabetes melitus using insulin injections administered with varying injection intervals
06/21/2012WO2012054509A3 Discovery of regulatory t cells programmed to suppress an immune response
06/21/2012WO2012051518A3 Compounds and methods for treating or preventing disease conditions associated with alpha-1-antitrypsin
06/21/2012WO2012051415A3 Inhibitors of acid ceramidase and the uses thereof in treating disorders including cancer
06/21/2012WO2012048022A3 Methods and compositions for therapeutic modulation of aldosterone levels in heart disease
06/21/2012WO2012047733A3 Treatment of acne by conditioned media
06/21/2012WO2012042023A3 Cyclosporine emulsion
06/21/2012WO2012040323A3 Multimeric il-15 soluble fusion molecules and methods of making and using same
06/21/2012WO2012040164A3 Tlr5 ligands, therapeutic methods, and compositions related thereto
06/21/2012WO2012037078A3 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
06/21/2012WO2012031240A3 Therapeutics for trauma induced factor v consumptive coagulopathy
06/21/2012WO2012031228A3 Llp2a-bisphosphonate conjugates for osteoporosis treatment
06/21/2012WO2012028961A3 Compositions and methods for treating friedreich's ataxia with interferon gamma
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 3163